[HTML][HTML] Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease

T Guo, D Zhang, Y Zeng, TY Huang, H Xu… - Molecular …, 2020 - Springer
Alzheimer's disease (AD) is the most common neurodegenerative disorder seen in age-
dependent dementia. There is currently no effective treatment for AD, which may be …

Microglia in neurodegeneration

S Hickman, S Izzy, P Sen, L Morsett, J El Khoury - Nature neuroscience, 2018 - nature.com
The neuroimmune system is involved in development, normal functioning, aging, and injury
of the central nervous system. Microglia, first described a century ago, are the main …

[HTML][HTML] Landscape of intercellular crosstalk in healthy and NASH liver revealed by single-cell secretome gene analysis

X Xiong, H Kuang, S Ansari, T Liu, J Gong, S Wang… - Molecular cell, 2019 - cell.com
Cell-cell communication via ligand-receptor signaling is a fundamental feature of complex
organs. Despite this, the global landscape of intercellular signaling in mammalian liver has …

Inflammation in CNS neurodegenerative diseases

J Stephenson, E Nutma, P van der Valk, S Amor - Immunology, 2018 - Wiley Online Library
Neurodegenerative diseases, the leading cause of morbidity and disability, are gaining
increased attention as they impose a considerable socioeconomic impact, due in part to the …

[HTML][HTML] Tau and neuroinflammation in Alzheimer's disease: Interplay mechanisms and clinical translation

Y Chen, Y Yu - Journal of neuroinflammation, 2023 - Springer
Alzheimer's Disease (AD) contributes to most cases of dementia. Its prominent
neuropathological features are the extracellular neuritic plaques and intercellular …

[HTML][HTML] New insights into the role of TREM2 in Alzheimer's disease

M Gratuze, CEG Leyns, DM Holtzman - Molecular neurodegeneration, 2018 - Springer
Alzheimer's disease (AD) is the leading cause of dementia. The two histopathological
markers of AD are amyloid plaques composed of the amyloid-β (Aβ) peptide, and …

[HTML][HTML] Early-onset Alzheimer's disease: what is missing in research?

T Ayodele, E Rogaeva, JT Kurup, G Beecham… - Current neurology and …, 2021 - Springer
Abstract Purpose of Review Early-onset Alzheimer's disease (EOAD), defined as
Alzheimer's disease (AD) occurring before age 65, is significantly less well studied than the …

Biomarkers used in Alzheimer's disease diagnosis, treatment, and prevention

YAR Mahaman, KS Embaye, F Huang, L Li, F Zhu… - Ageing research …, 2022 - Elsevier
Abstract Alzheimer's disease (AD), being the number one in terms of dementia burden, is an
insidious age-related neurodegenerative disease and is presently considered a global …

[HTML][HTML] Inflammatory response in the CNS: friend or foe?

M Sochocka, BS Diniz, J Leszek - Molecular neurobiology, 2017 - Springer
Inflammatory reactions could be both beneficial and detrimental to the brain, depending on
strengths of their activation in various stages of neurodegeneration. Mild activation of …

[HTML][HTML] Late onset Alzheimer's disease genetics implicates microglial pathways in disease risk

AG Efthymiou, AM Goate - Molecular neurodegeneration, 2017 - Springer
Alzheimer's disease (AD) is a highly heritable complex disease with no current effective
prevention or treatment. The majority of drugs developed for AD focus on the amyloid …